Breaking News: Bridgewater Exits Salesforce
In a move that could reshape how patient investors think about long-duration bets, Bridgewater Associates has exited its stake in Salesforce, CRM. The decision arrives as markets negotiate a tougher near-term backdrop for software shares, even as high-quality compounders retain strong fundamentals. The exit is sparking questions about whether durable, recurring-growth franchises still deserve premium prices in a volatile year.
bridgewater just sold salesforce. The commentary around the move centers on whether the timing reflects a reassessment of Salesforce’s growth runway or a broader reallocation toward shorter-duration bets that can be funded in a higher-rate environment. For patient capital, the question is whether Salesforce still offers the reliable cash generation and expanding margins that long-term investors typically hunt for.
The Case for Patience in Durable Growth Names
Strategists say today’s exit should not be read as a verdict on Salesforce’s business quality. Rather, it highlights a shift in portfolio construction among major managers who now balance growth durability with more cautious near-term outlooks. For patient capital, the core thesis remains intact: Salesforce is a recurring-revenue engine with a track record of converting billings into free cash flow over extended horizons. The challenge is translating that durability into an entry point that aligns with a refreshed risk-reward framework.
Analysts point to the resilience of subscription revenue and the scale of remaining performance obligations as the key drivers for long-term holders. The argument says if a firm can consistently convert active subscriptions into free cash flow streams even as growth decelerates, it can support a stable multiple over time. The exit, then, may be a sign to re-evaluate the price paid for that durability rather than a call to abandon the thesis altogether.
Salesforce’s Durability: What the Numbers Say
Salesforce’s business model remains anchored in high-quality, recurring revenue, with subscription and support revenue accounting for roughly 95% of total revenues. Remaining performance obligations (RPO) sit at a substantial level, reflecting both billed and unbilled work on the books. The latest figures show RPO hovering above the $72 billion mark, with the portion that is billed and unbilled currently around $33.6 billion—an increase of about 14% year over year. This setup underscores a durable cash-generation engine, even as demand cycles shift.
- Gross margin: 77.68%; operating margin: 21.47%
- FY26 revenue: $41.525 billion, up 9.58% year over year
- FY27 revenue guide: $45.9 billion to $46.2 billion
- FY30 revenue target: raised to $63 billion
- Agentforce ARR: $1.2 billion, up 205% from prior years
- Shareholder returns: free cash flow rose to $14.4 billion, up 15.83% YoY; share count declined by 100 million; dividend rose 5.8% year over year
- Market position: Salesforce remains a backbone for many enterprise AI initiatives, with industry observers noting that a large share of Forbes Top 50 AI companies rely on its platform
The numbers point to a durable cash-generating core. Yet the market has increasingly priced in a period of slower growth for software franchises, especially those with heavy enterprise commitments and long contract cycles. Salesforce’s model, which blends long-term contracts with a robust ecosystems of developers and partners, has historically rewarded patient owners who can tolerate quarterly volatility for a longer horizon.
What the Exit Means for Salesforce Bulls and Bears
For bulls, the exit is a reminder that even the strongest compounders are not immune to shifting appetite and price discipline. Bulls argue that Salesforce’s subscription backbone, consistency of cash flow, and potential for margin expansion—driven by automation, cross-sell, and increased ARR—still justify a premium valuation in a world of rising capital costs.
For bears or neutral observers, the move intensifies focus on growth durability and capital allocation discipline. If a major investor is willing to step back, others may question whether the current pricing fully reflects the time horizon required to unlock Salesforce’s longer-term opportunities, including international expansion, vertical productization, and AI-enabled workflows that could lift efficiency at scale.
In the broader market, the exit is part of a wider drawdown pattern seen in several software franchises that previously enjoyed multiple expansions during AI-driven growth cycles. Yet, as one senior equity strategist notes, the core business questions remain unchanged: can Salesforce sustain its revenue growth, preserve high gross margins, and convert more of its market potential into free cash flow in a slower-growth environment?
Market Context: 2026 Conditions and the Path Forward
The investing backdrop in 2026 blends continued digital transformation with cautious macro signals. While AI and cloud infrastructure remain accelerants for software demand, investors are increasingly sensitive to cost controls, customer concentration risk, and the need for evidence of durable operating leverage. In this climate, patient capital seeks names that can compound value over several years, rather than deliver quick, episodic gains.
Salesforce remains a focal point within that framework because its platform underpins a broad ecosystem of enterprise tools—from customer relationship management to marketing automation and analytics. The company’s ability to monetize higher-value workloads, deepen integration with AI-powered features, and maintain a disciplined capital allocation plan will likely determine whether the stock re-rates to a higher multiple or tolerates a more modest revaluation in the near term.
What Investors Should Watch Next
1) Free cash flow trajectory: Salesforce’s FCF growth of 15.83% to $14.4 billion signals cash efficiency improving alongside revenue expansion. Investors will watch whether cash flow conversion accelerates further as operating margins stabilize and capital expenditure remains in check.
2) Margin discipline: With gross margins near 78% and operating margins around 21%, the company sits at a favorable margin structure. The question remains whether investment in AI-driven product lines will compress margins or unlock stepped-up profitability in coming quarters.
3) Growth runway vs. price: The FY27 guide implies continued top-line expansion, but the pace and quality of that growth will be the deciding factor for long-duration buyers. A path to $63 billion in revenue by FY30 would bolster the argument for patient capital, even if near-term multiples contract.
4) Reference customer base and AI integration: The claim that a large share of top AI firms rely on Salesforce remains a strong credibility signal. If Salesforce can convert that platform dependency into higher adoption of premium AI capabilities and cross-sell across its product suite, the case for a durable moat strengthens for patient investors.
Bottom Line: A Cautionary Yet Encouraging Signal
The markets may see the exit of a prominent, patient-capital manager as a calibration rather than a conclusion. For those who chase long-term compounders with structural moats, Salesforce remains a compelling case study in the power of recurring revenues, predictable cash flows, and disciplined capital returns. The move adds a layer of nuance to the investment narrative: durable growth can coexist with market unpredictability, but entry points matter as much as the business fundamentals.
As investors digest the implications of this latest development, the broader takeaway is clear: bridgewater just sold salesforce. The question now for patient capital is not whether Salesforce can win in the long run, but at what price and on what terms does that long run begin to look attractive again in a shifting market landscape.
Discussion